@theconversation.com a year ago Why some people got blood clots after the AstraZeneca vaccine – new clues
@rt.com 4 years ago Argentina 2nd to approve Oxford-AstraZeneca Covid-19 jab, as EU expected to soon follow suit
@rt.com 4 years ago AstraZeneca’s Covid-19 vaccine shows average efficiency of 70%
@forbes.com 5 years ago AstraZeneca Covid-19 Coronavirus Vaccine Begins Phase 3 Trial In U.S.
@WSJ 5 years ago AstraZeneca has signed new agreements aimed at broadening global distribution of a coronavirus vaccine being developed by researchers on.wsj.com
@cjr.org 4 years ago The AstraZeneca vaccine and our ongoing uncertainty problem
@dailywire.com 4 years ago U.K. Becomes First Nation To Approve AstraZeneca Coronavirus Vaccine
@abc.net.au 4 years ago AstraZeneca says COVID-19 vaccine developed with Oxford can be up to 90 per cent effective
@dailywire.com 5 years ago AstraZeneca Might Receive Emergency Use Authorization For Its Coronavirus Vaccine — In October: Report
@dailywire.com 5 years ago U.S. Gives $1.2 Billion To UK Attempt At Vaccine, 300 Million Doses Could Be Ready By October
@cjr.org 4 years ago Political warfare, inequity, and insufficient data in coverage of the vaccine rollout
@nytimesworld 4 years ago Britain became the first country to give emergency authorization to the coronavirus vaccine developed by AstraZeneca and the University of Oxford. Follow our updates on the pandemic: nyti.ms
@rt.com 4 years ago AstraZeneca vaccine volunteer developed spinal inflammation & ‘rare neurological condition’ after two doses – report
@forbes.com 5 years ago Promising Sign As Coronavirus Vaccine Developed By AstraZeneca And Oxford University Appears Safe, Early Trials Show
@nytimesworld 4 years ago An 82-year-old in Britain became the first person in the world to receive the clinically authorized, fully tested coronavirus vaccine developed by the University of Oxford and AstraZeneca. Follow our updates on the pandemic. nyti.ms
@abc.net.au 4 years ago UK approves Oxford-AstraZeneca COVID-19 vaccine
@nytimesworld 5 years ago The drug company AstraZeneca has paused its coronavirus vaccine trials after a participant developed a serious illness. The company is investigating whether it was tied to the vaccine. nyti.ms
@WSJ 5 years ago A leading coronavirus-vaccine candidate being developed by University of Oxford researchers and pharmaceutical company AstraZeneca showed positive results in early trials, raising the prospect that a shot could be available by the end of this year on.wsj.com